Jørgensen Karsten
Breast Cancer Res. 2012 Jul 13;14(4):107. doi: 10.1186/bcr3212.
Herein I argue that mammographic screening has not delivered on its fundamental premise: to reduce the incidence of advanced breast cancer. Indeed, achieving this goal is required if screening is to reduce breast cancer mortality or mastectomy use. Rather, screening has caused substantial increases in the incidence of in situ and early invasive cancers. Moreover, evidence indicates that these screen-detected cancers are unlikely to be cases that were 'caught early', but instead represent women who would not have been diagnosed in the absence of screening and who, as a result, have received harmful, unnecessary treatment. If true, these observations raise the specter that screening creates breast cancer patients and that this practice carries little or no benefit.
在此我认为,乳腺钼靶筛查并未实现其基本前提:降低晚期乳腺癌的发病率。事实上,如果筛查要降低乳腺癌死亡率或减少乳房切除术的使用,就必须实现这一目标。相反,筛查已导致原位癌和早期浸润癌的发病率大幅上升。此外,有证据表明,这些通过筛查发现的癌症不太可能是“早期发现”的病例,而是代表那些在没有筛查的情况下不会被诊断出来的女性,因此她们接受了有害的、不必要的治疗。如果情况属实,这些观察结果引发了一种担忧,即筛查制造了乳腺癌患者,而且这种做法几乎没有益处。